about
Coronavirus-induced demyelination of neural pathways triggers neurogenic bladder overactivity in a mouse model of multiple sclerosis.Prophylactic octreotide for pancreatoduodenectomy: more harm than good?HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.Defining the practice of pancreatoduodenectomy around the worldNovel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences?The influence of fellowship training on the practice of pancreatoduodenectomy.Predictive factors for pancreatic fistula following pancreatectomy.Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception.A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.Pancreas fistula risk prediction: implications for hospital costs and payments.Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma.Preoperative radiotherapy in the management of retroperitoneal liposarcoma.A prognostic model for resectable soft tissue and cutaneous angiosarcoma.Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification.Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy.Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer: Role for Immune Monitoring.Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer.The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy.Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification.Prophylactic octreotide in pancreatoduodenectomy: response to Yang et al.Evaluating the efficacy of pre-operative fistula risk assessment.Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group.Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.Characterization and Optimal Management of High-Risk Pancreatic Anastomoses During Pancreatoduodenectomy.Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula after Distal Pancreatectomy: A Multi-Institutional Analysis and External Validation.Surgical experience and the practice of pancreatoduodenectomy.
P50
Q34131056-91BB7BD7-DDFB-4F01-ADAF-C89D2CC006C1Q34548950-75797304-2C9D-4C9C-AB59-3C354CFB61C6Q36112574-0AAAACA3-18B6-41A5-8466-AD1BA717AF8FQ36278702-AEF58C74-B133-4F19-9AA5-E4951F0CA129Q36336701-48175D8A-8DED-43A6-AC37-8E9C36F3A0BEQ37350324-1DB2A88A-2B75-4D24-B062-B3B232D3EB06Q37484590-2AB57CD2-7E16-4F38-AC59-4FAF87397404Q38222990-43534054-7411-4682-B0B9-990A2CDB31D1Q38672690-6B5BC007-B912-4FE4-BBDD-7EE540A736DFQ38927253-272E0758-AFA1-4999-953E-0D2A0B5B7204Q38959653-108FE5EA-EF21-47F3-9EDF-95E15D4E759BQ39058134-714028C1-A983-49CA-85FD-C5D7EB0F0D08Q39155964-ED7F7E8D-D5A4-4A51-8DB6-9B109C90C1B7Q39188702-CFD0BEA7-59AD-4BC5-8F3F-483BBC186CE5Q39245266-3693843A-477B-4F49-BCE2-70E42721A731Q39341663-8AAC51AF-8100-4459-96AE-DE4B2D091BF4Q39632275-A9017159-DD4A-4E1B-A540-547C5067FE3AQ39697175-C419F691-CF71-495F-ABB7-5F26FAD68FA8Q39731689-B2FDEF13-AED8-49BD-B8C2-8B5A27D7BD68Q39841938-B8047A61-E3AE-4D8A-BB24-E4956FF4A482Q40155406-D351191D-E5CF-4FC4-BED8-65F06EABAE63Q40155719-E5D3CC54-C492-47DB-9D68-2807B0ACFA6AQ40158629-925AFF86-1DC6-4D6A-B5F3-52F53E6C8859Q40297931-F734FCCA-C08D-47B8-A915-942A8B155D68Q40670901-82E017C9-FD6E-454F-89FC-E0A851364442Q40749991-BD57CCBB-D2CE-4C78-AF20-95BC30C9B801Q40775168-73C389F1-07AD-4B76-B793-3E8E3D43FE2DQ40810113-F1B375FD-D45B-4D4B-88AF-57D4174552C7Q40949443-40318F24-3804-4F15-A247-19C7CE81EB94Q41003007-3AB849BD-9EF8-4211-9FA2-EC481E1300B9Q41048406-C419707C-DD24-4A22-A31F-6F7552E30025Q41478702-BC93876E-98FF-4B4C-8536-0701D98A7E81Q43196452-8672E8CD-4061-4AA7-A98B-201F1BDB1820Q43196453-3202C205-9B92-490C-B7BF-300018B67E8EQ43653545-4A0A023A-2B20-4F8E-8680-93CFA0BB0AADQ47257982-B407339A-4F8A-41CE-8678-D9D4F70E83D4Q47846684-500B0625-ED09-4297-9343-552C69D4C9B9Q48771177-1EA4EC18-9A8A-4093-BC61-C3AFC117470DQ49922740-B4ACFB30-503C-4B96-AEDC-9EA8477DD1B2Q50430416-5521981A-DEB2-480B-9229-15D55CC4C6E8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew T McMillan
@ast
Matthew T McMillan
@en
Matthew T McMillan
@es
Matthew T McMillan
@nl
type
label
Matthew T McMillan
@ast
Matthew T McMillan
@en
Matthew T McMillan
@es
Matthew T McMillan
@nl
prefLabel
Matthew T McMillan
@ast
Matthew T McMillan
@en
Matthew T McMillan
@es
Matthew T McMillan
@nl
P106
P1153
56221726100
P31
P496
0000-0002-1172-9273